Notice of Intent to Sole Source - Military Aviators Cancer Study

The Defense Health Agency intends to award a Firm Fixed Price sole source purchase order to the North American Association of Central Cancer Registries, Inc. for the Military Aviators Cancer Study Phase 2 and NDAA FY26 Administrative Support Coordination, pursuant to RFO 12.102(a). This action continues the work initiated in Phase 1 of the study, which was mandated by Section 750 of the FY21 National Defense Authorization Act and utilized NAACCR’s Virtual Pooled Registry Cancer Linkage System to access state cancer registry data. Phase 2 is legally required to identify specific cancer risk factors among military aircrew and ground crew populations, and NAACCR will serve as the central coordinating body to manage and distribute funds to participating state cancer registries to support administrative, personnel, and general and administrative costs necessary for data access and linkage. The contract period begins on August 1, 2026, and extends through July 31, 2027, with an option period through January 31, 2028, under FAR 52.217-8. Certified cost or pricing data will not be required, and the price is determined to be fair and reasonable based on an Independent Government Estimate. The solicitation is issued under solicitation number HT9427-26-SS-0002, with a NAICS code of 813920, and the place of performance is in Springfield, Illinois, at NAACCR’s headquarters. The notice of intent was posted on July 9, 2026, and interested parties must submit written responses demonstrating their capability and interest by 11:00 a.m. Eastern Standard Time on July 24, 2026, to the designated point of contact, Ms. Jennifer Bassett. No telephone inquiries will be accepted, and the government retains full discretion to determine whether to proceed with a sole source award or open the requirement to competition based on responses received. No other firm has been identified as capable of performing this unique task, as NAACCR holds the established infrastructure, expertise, and statutory continuity from Phase 1, justifying the sole source approach under the authority of FAR 12.102(a). The agency is the Defense Health Agency Contracting Activity, with secondary contact provided by Jessica E. Greene. There are no specified packaging, inspection, or submission format requirements beyond the need for a formal written